1. Home
  2. TNGX vs CDP Comparison

TNGX vs CDP Comparison

Compare TNGX & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$24.77

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo COPT Defense Properties of Beneficial Interest

CDP

COPT Defense Properties of Beneficial Interest

HOLD

Current Price

$37.49

Market Cap

4.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNGX
CDP
Founded
2014
1988
Country
United States
United States
Employees
137
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
TNGX
CDP
Price
$24.77
$37.49
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$21.78
$34.57
AVG Volume (30 Days)
2.0M
747.1K
Earning Date
05-08-2026
04-27-2026
Dividend Yield
N/A
4.14%
EPS Growth
26.89
8.94
EPS
N/A
0.74
Revenue
$62,384,000.00
$763,923,000.00
Revenue This Year
N/A
$1.18
Revenue Next Year
N/A
$3.71
P/E Ratio
N/A
$50.62
Revenue Growth
48.29
1.41
52 Week Low
$6.25
$27.06
52 Week High
$34.39
$38.90

Technical Indicators

Market Signals
Indicator
TNGX
CDP
Relative Strength Index (RSI) 45.55 57.67
Support Level $25.33 $36.21
Resistance Level $25.76 $38.06
Average True Range (ATR) 1.34 0.49
MACD -0.14 -0.02
Stochastic Oscillator 35.47 81.87

Price Performance

Historical Comparison
TNGX
CDP

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. The company has two reportable segments: Defense/IT Portfolio; and Other. Defense/IT Portfolio includes sub-segments such as: Fort George G. Meade and the Baltimore/Washington Corridor (Fort Meade/BW Corridor); Redstone Arsenal in Huntsville, Alabama; Northern Virginia Defense/IT Locations (NoVA Defense/IT); Lackland Air Force Base in San Antonio, Texas; locations serving the U.S. Navy (Navy Support); and data center shells in Northern Virginia.

Share on Social Networks: